Injection sclerotherapy for esophageal varices caused by schistosomal hepatic fibrosis
Related Experiment Video
Updated: Aug 13, 2026

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension
Published on: November 15, 2024
Abstract:
Sixty patients with esophageal varices caused by schistosomal hepatic fibrosis were managed by injection sclerotherapy. Bleeding was controlled in 17 of 20 patients (85%) with acute bleeding from varices. The remaining 40 patients were either unfit for operation or had a recurrence of variceal bleeding after operation. In a period of follow-up that ranged from 14 to 31 months (mean 18.4 months), 11 patients (18.3%) had a recurrence of bleeding that was controlled and four patients (6.7%) had a fatal recurrence of bleeding. The overall mortality rate was 25% (15 patients), and 34 patients (56.7%) had no recurrence of bleeding.
Related Concept Videos
Esophageal Strictures-I: Introduction
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Esophageal Varices-I: Introduction
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Portal Hypertension

